AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®

ConvaTec Inc.105 enrolled

Overview

Study is to provide a blinded assessment of wound closure status utilizing photographs collected as per standard of care (SOC) during the AAA RCT (WC-22-435).

The purpose of the study is to provide a blinded (treatment arm, timepoint) assessment of wound closure status utilizing photographs collected as per standard of care (SOC) during the AAA Randomized Controlled Trial (RCT) (WC-22-435).

Study Type

OBSERVATIONAL

Enrollment

105

Conditions

Venous Leg Ulcer Diabetic Foot

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All subjects from the intention to treat (ITT) population with wound photograph(s) corresponding to the study visit date (WC-22-435) indicating wound closure or their 12-week visit, whichever came first Exclusion Criteria: * Subjects whose photographs are deemed of insufficient quality to make determination of closure

Locations (1)

Essen University Hospital

Essen, Germany

Outcomes

Primary Outcomes

Wound closure at 12 weeks

Incidence of wound closure at 12 weeks, defined as 100% epithelialization of the wound surface, assessed by a blinded observer through photographic evidence

Time frame: 12 week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.